These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7564121)

  • 1. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
    Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of advanced glycation end-products in the progression of diabetic nephropathy.
    Makino H; Shikata K; Kushiro M; Hironaka K; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Nephrol Dial Transplant; 1996; 11 Suppl 5():76-80. PubMed ID: 9044313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesangial deposition of type I collagen in human glomerulosclerosis.
    Glick AD; Jacobson HR; Haralson MA
    Hum Pathol; 1992 Dec; 23(12):1373-9. PubMed ID: 1468774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-products in diabetic nephropathy.
    Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
    Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
    Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
    Sakai H; Jinde K; Suzuki D; Yagame M; Nomoto Y
    Nephrol Dial Transplant; 1996; 11 Suppl 5():66-71. PubMed ID: 9044311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular extracellular matrices in rat diabetic glomerulopathy by scanning electron microscopy.
    Makino H; Yamasaki Y; Hironaka K; Ota Z
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):19-24. PubMed ID: 1352071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products.
    Xu D; Kyriakis JM
    J Biol Chem; 2003 Oct; 278(41):39349-55. PubMed ID: 12871951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel-Wilson type).
    Müller-Höcker J; Weiss M; Thoenes GH; Grund A; Nerlich A
    Pathol Res Pract; 2002; 198(5):375-9. PubMed ID: 12092775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
    Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
    Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
    J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.
    Nakatani S; Ishimura E; Mori K; Fukumoto S; Yamano S; Wei M; Emoto M; Wanibuchi H; Inaba M
    Nephron Clin Pract; 2012; 122(3-4):114-21. PubMed ID: 23689482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of advanced glycation endproducts in the kidney of experimental diabetic rats.
    Shikata K; Makino H; Sugimoto H; Kushiro M; Ota K; Akiyama K; Araki N; Horiuchi S; Ota Z
    J Diabetes Complications; 1995; 9(4):269-71. PubMed ID: 8573744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A; Schleicher E
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
    Ohashi S; Abe H; Takahashi T; Yamamoto Y; Takeuchi M; Arai H; Nagata K; Kita T; Okamoto H; Yamamoto H; Doi T
    J Biol Chem; 2004 May; 279(19):19816-23. PubMed ID: 15004023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy.
    Imai N; Nishi S; Suzuki Y; Karasawa R; Ueno M; Shimada H; Kawashima S; Nakamaru T; Miyakawa Y; Araki N; Horiuchi S; Gejyo F; Arakawa M
    Nephron; 1997; 76(2):153-60. PubMed ID: 9200406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.